Abbott India Limited

ABBOTINDIA

INE358A01014

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-04-29 am EDT			5-day change	1st Jan Change
26,278 ^INR	+1.60%		+0.56%	+14.99%

Apr. 12	Abbott India Limited Appoints Murari Ranganathan as Commercial Director	CI
Mar. 19	Abbott India's Managing Director Exits	MT

Abbott India : Voting Results and Scrutinizer’s Report of 79th Annual General Meeting - August 9, 2023

August 11, 2023 at 02:30 am EDT

			Abbott India Limited
Date of the AGM			August 9, 2023
Total number of shareholders on record date			70,757
No. of shareholders present in the meeting either in person or through proxy:
Promoters and Promoter Group:			Not Applicable
Public:			Not Applicable
No. of Shareholders attended the meeting through Video Conferencing
Promoters and Promoter Group:			3
Public:			79

Resolution No.	1
	ORDINARY - To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 together with the Reports of Directors and
Resolution required: (Ordinary/ Special)	Auditors thereon.
Whether promoter/ promoter group are
interested in the agenda/resolution?	NO
				% of Votes Polled				% of Votes in	% of Votes
				on outstanding				favour on votes	against on votes
		No. of shares held	No. of votes	shares	No. of Votes - in	No. of Votes -		polled	polled
Category	Mode of Voting	(1)	polled (2)	(3)=[(2)/(1)]* 100	favour (4)	against (5)		(6)=[(4)/(2)]*100	(7)=[(5)/(2)]*100	Votes Invalid		Votes Abstained
	E-Voting		15,934,048	100.0000	15,934,048		0	100.0000	0.0000		0		0
	Poll	15,934,048	0	0.0000	0		0	0.0000	0.0000		0		0
	Postal Ballot (if

Promoter and Promoter Group	applicable)		0	0.0000	0		0	0.0000	0.0000		0		0
	Total		15,934,048	100.0000	15,934,048		0	100.0000	0.0000		0		0
	E-Voting		1,671,791	87.2394	1,671,791		0	100.0000	0.0000		0		0
	Poll	1,916,326	0	0.0000	0		0	0.0000	0.0000		0		0
	Postal Ballot (if

Public- Institutions	applicable)		0	0.0000	0		0	0.0000	0.0000		0		0
	Total		1,671,791	87.2394	1,671,791		0	100.0000	0.0000		0		0
	E-Voting		12,234	0.3599	12,227		7	99.9427	0.0572		0		0
	Poll	3,398,928	327	0.0096	327		0	100.0000	0.0000		0		0
	Postal Ballot (if

Public- Non Institutions	applicable)		0	0.0000	0		0	0.0000	0.0000		0		0
	Total		12,561	0.3695	12,554		7	99.9443	0.0557		0		0
	Total	21,249,302	17,618,400	82.9128	17,618,393		7	100.0000	0.0000		0		0

Resolution No.	2
Resolution required: (Ordinary/ Special)	ORDINARY - To declare a final dividend of Rs. 180/- and special dividend of Rs. 145/- per Equity Share for the financial year ended March 31, 2023.
Whether promoter/ promoter group are
interested in the agenda/resolution?	NO
				% of Votes Polled				% of Votes in	% of Votes
				on outstanding				favour on votes	against on votes
		No. of shares held	No. of votes	shares	No. of Votes - in	No. of Votes -		polled	polled
Category	Mode of Voting	(1)	polled (2)	(3)=[(2)/(1)]* 100	favour (4)	against (5)		(6)=[(4)/(2)]*100	(7)=[(5)/(2)]*100	Votes Invalid		Votes Abstained
	E-Voting		15,934,048	100.0000	15,934,048		0	100.0000	0.0000		0	0
	Poll	15,934,048	0	0.0000	0		0	0.0000	0.0000		0	0
	Postal Ballot (if

Promoter and Promoter Group	applicable)		0	0.0000	0		0	0.0000	0.0000		0	0
	Total		15,934,048	100.0000	15,934,048		0	100.0000	0.0000		0	0
	E-Voting		1,674,390	87.3750	1,674,390		0	100.0000	0.0000		0	0
	Poll	1,916,326	0	0.0000	0		0	0.0000	0.0000		0	0
	Postal Ballot (if

Public- Institutions	applicable)		0	0.0000	0		0	0.0000	0.0000		0	0
	Total		1,674,390	87.375	1,674,390		0	100.0000	0.0000		0	0
	E-Voting		12,153	0.3576	12,151		2	99.9835	0.0164		0	0
	Poll	3,398,928	327	0.0096	327		0	100.0000	0.0000		0	0
	Postal Ballot (if

Public- Non Institutions	applicable)		0	0.0000	0		0	0.0000	0.0000		0	0
	Total		12,480	0.3672	12,478		2	99.9840	0.0160		0	0
	Total	21,249,302	17,620,918	82.9247	17,620,916		2	100.0000	0.0000		0	0

Resolution No.	3
Resolution required: (Ordinary/ Special)	ORDINARY - To appoint a Director in place of Mr Kaiyomarz Marfatia (DIN : 03449627), who retires by rotation and being eligible, offers himself for re-appointment.
Whether promoter/ promoter group are
interested in the agenda/resolution?	NO
				% of Votes Polled			% of Votes in	% of Votes
				on outstanding			favour on votes	against on votes
		No. of shares held	No. of votes	shares	No. of Votes - in	No. of Votes -	polled	polled
Category	Mode of Voting	(1)	polled (2)	(3)=[(2)/(1)]* 100	favour (4)	against (5)	(6)=[(4)/(2)]*100	(7)=[(5)/(2)]*100	Votes Invalid		Votes Abstained
	E-Voting		15,934,048	100.0000	15,934,048	0	100.0000	0.0000		0	0
	Poll	15,934,048	0	0.0000	0	0	0.0000	0.0000		0	0
	Postal Ballot (if

Promoter and Promoter Group	applicable)		0	0.0000	0	0	0.0000	0.0000		0	0
	Total		15,934,048	100.0000	15,934,048	0	100.0000	0.0000		0	0
	E-Voting		1,671,791	87.2394	1,671,791	0	100.0000	0.0000		0	0
	Poll	1,916,326	0	0.0000	0	0	0.0000	0.0000		0	0
	Postal Ballot (if

Public- Institutions	applicable)		0	0.0000	0	0	0.0000	0.0000		0	0
	Total		1,671,791	87.2394	1,671,791	0	100.0000	0.0000		0	0
	E-Voting		12,149	0.3574	11,745	404	96.6746	3.3253		0	0
	Poll	3,398,928	327	0.0096	327	0	100.0000	0.0000		0	0
	Postal Ballot (if

Public- Non Institutions	applicable)		0	0.0000	0	0	0.0000	0.0000		0	0
	Total		12,476	0.367	12,072	404	96.7618	3.2382		0	0
	Total	21,249,302	17,618,315	82.9124	17,617,911	404	99.9977	0.0023		0	0

Resolution No.	4
Resolution required: (Ordinary/ Special)	ORDINARY - To appoint a Director in place of Ms Sabina Ewing (DIN : 09201770), who retires by rotation and being eligible, offers herself for re-appointment.
Whether promoter/ promoter group are
interested in the agenda/resolution?	NO
				% of Votes Polled			% of Votes in	% of Votes
				on outstanding			favour on votes	against on votes
		No. of shares held	No. of votes	shares	No. of Votes - in	No. of Votes -	polled	polled
Category	Mode of Voting	(1)	polled (2)	(3)=[(2)/(1)]* 100	favour (4)	against (5)	(6)=[(4)/(2)]*100	(7)=[(5)/(2)]*100	Votes Invalid		Votes Abstained
	E-Voting		15,934,048	100.0000	15,934,048	0	100.0000	0.0000		0	0
	Poll	15,934,048	0	0.0000	0	0	0.0000	0.0000		0	0
	Postal Ballot (if

Promoter and Promoter Group	applicable)		0	0.0000	0	0	0.0000	0.0000		0	0
	Total		15,934,048	100.0000	15,934,048	0	100.0000	0.0000		0	0
	E-Voting		1,671,791	87.2394	1,521,138	150,653	90.9885	9.0114		0	0
	Poll	1,916,326	0	0.0000	0	0	0.0000	0.0000		0	0
	Postal Ballot (if

Public- Institutions	applicable)		0	0.0000	0	0	0.0000	0.0000		0	0
	Total		1,671,791	87.2394	1,521,138	150,653	90.9885	9.0115		0	0
	E-Voting		12,153	0.3576	11,749	404	96.6757	3.3242		0	0
	Poll	3,398,928	327	0.0096	327	0	100.0000	0.0000		0	0
	Postal Ballot (if

Public- Non Institutions	applicable)		0	0.0000	0	0	0.0000	0.0000		0	0
	Total		12,480	0.3672	12,076	404	96.7628	3.2372		0	0
	Total	21,249,302	17,618,319	82.9125	17,467,262	151,057	99.1426	0.8574		0	0

Resolution No.	5
	ORDINARY - To ratify remuneration of Rs 0.08 Crores plus applicable taxes and reimbursement of reasonable out-of-pocket expenses payable to M/s Kishore Bhatia & Associates
Resolution required: (Ordinary/ Special)	(Registration No. 00294), Cost Auditors for the financial year 2023-24.
Whether promoter/ promoter group are
interested in the agenda/resolution?	NO
				% of Votes Polled				% of Votes in	% of Votes
				on outstanding				favour on votes	against on votes
		No. of shares held	No. of votes	shares	No. of Votes - in	No. of Votes -		polled	polled
Category	Mode of Voting	(1)	polled (2)	(3)=[(2)/(1)]* 100	favour (4)	against (5)		(6)=[(4)/(2)]*100	(7)=[(5)/(2)]*100	Votes Invalid		Votes Abstained
	E-Voting		15,934,048	100.0000	15,934,048		0	100.0000	0.0000		0		0
	Poll	15,934,048	0	0.0000	0		0	0.0000	0.0000		0		0
	Postal Ballot (if

Promoter and Promoter Group	applicable)		0	0.0000	0		0	0.0000	0.0000		0		0
	Total		15,934,048	100.0000	15,934,048		0	100.0000	0.0000		0		0
	E-Voting		1,671,791	87.2394	1,671,791		0	100.0000	0.0000		0		0
	Poll	1,916,326	0	0.0000	0		0	0.0000	0.0000		0		0
	Postal Ballot (if

Public- Institutions	applicable)		0	0.0000	0		0	0.0000	0.0000		0		0
	Total		1,671,791	87.2394	1,671,791		0	100.0000	0.0000		0		0
	E-Voting		12,153	0.3576	12,118		35	99.7120	0.2879		0		0
	Poll	3,398,928	327	0.0096	327		0	100.0000	0.0000		0		0
	Postal Ballot (if

Public- Non Institutions	applicable)		0	0.0000	0		0	0.0000	0.0000		0		0
	Total		12,480	0.3672	12,445		35	99.7196	0.2804		0		0
	Total	21,249,302	17,618,319	82.9125	17,618,284		35	99.9998	0.0002		0		0

Attachments

Original Link
Original Document
Permalink

Disclaimer

Abbott India Limited published this content on 11 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2023 06:29:03 UTC.

Latest news about Abbott India Limited

Abbott India Limited Appoints Murari Ranganathan as Commercial Director	Apr. 12	CI
Abbott India's Managing Director Exits	Mar. 19	MT
Abbott India Limited Announces Resignation of Sandeep Reddy - Commercial Director - Women's Health, Metabolics and International Business, with Effect from June 5, 2024	Mar. 15	CI
Abbott India Names Managing Director	Mar. 13	MT
GSK India arm's Q3 profit falls on government price cap	Feb. 12	RE
Abbott India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 14	CI
Abbott India Managing Director to Step Down in March 2024	Dec. 19	MT
Abbott India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
INDIA STOCKS-Indian shares set for muted opening; Delta Corp in focus after tax notice	23-09-24	RE
Abbott India warns of laxatives shortage in tussle with Goa regulator	23-09-22	RE
Goa state warns Abbott India on antacid license suspension	23-09-14	RE
Abbott India Limited Approves Appointment of Sangeeta Shetty as Company Secretary, Effective September 14, 2023	23-08-09	CI
Abbott India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09	CI
Abbott India Limited Appoints Ms Richa Tripathi as Associate Director, Effective August 3, 2023	23-07-24	CI
INDIA STOCKS-Indian shares recover from weak start on buying at key levels	23-05-22	RE
Abbott India Limited Approves the Appointment of Sridhar Kadangode as Chief Financial Officer, Effective July 1, 2023	23-05-19	CI
Abbott's India arm posts 9.5% rise in fourth-quarter profit	23-05-19	RE
Abbott India's Net Profit Climbs in Fiscal Q4	23-05-19	MT
Abbott India Limited Approves the Appointment of Mahadeo Karnik as an Additional and Non-Executive Director on the Board, Effective July 1, 2023	23-05-19	CI
Abbott India Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-19	CI
Abbott India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-19	CI
Abbott India Limited Recommends Payment of Final Dividend for the Year Ended March 31, 2023, Payable on or After, August 16, 2023	23-05-19	CI
Abbott India Limited Recommends Special Dividend for the Year Ended March 31, 2023, Payable on or After, August 16, 2023	23-05-19	CI
Pfizer's India unit posts 3% rise in Q4 profit	23-05-15	RE
Abbott India Limited Announces the Resignation of Krupa Anandpara as Company Secretary and Compliance Officer, Effective on June 30, 2023	23-04-07	CI

Chart Abbott India Limited

Duration

Period

More charts

Company Profile

Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Abbott India Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ABBOTT INDIA LIMITED	+14.99%	6.59B
ELI LILLY AND COMPANY	+25.61%	661B
NOVO NORDISK A/S	+26.74%	566B
JOHNSON & JOHNSON	-6.64%	352B
MERCK & CO., INC.	+19.42%	332B
ABBVIE INC.	+3.49%	283B
ASTRAZENECA PLC	+13.43%	231B
NOVARTIS AG	+4.71%	200B
ROCHE HOLDING AG	-9.53%	195B
AMGEN INC.	-4.75%	145B

Other Pharmaceuticals

Abbott India Limited

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Abbott India : Voting Results and Scrutinizer’s Report of 79th Annual General Meeting - August 9, 2023

Latest news about Abbott India Limited

Chart Abbott India Limited

Company Profile

Income Statement Evolution

Ratings for Abbott India Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals